SCHEMBL6000648

SCHEMBL6000648

CN(Cc1ccc(C2CCCCC2)cc1)c1ccc(-c2csc(CN3CCN(CC(=O)O)CC3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.42
ITGA2B P08514 6/20 0.42
CTSL P07711 2/20 0.39
CTSB P07858 2/20 0.39
CTSS P25774 2/20 0.39
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MRE11 P49959 1/20 0.37
TRPA1 O75762 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36
S1PR3 Q99500 1/20 0.36
S1PR5 Q9H228 1/20 0.36
HTT P42858 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
ENPP2 Q13822 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000564 0.90 S1PR1 (0.42) ITGB3ITGA2BCTSLCTSBCTSS
SCHEMBL5999096 0.86 S1PR1 (0.44) SMN1; SMN2S1PR4S1PR1S1PR3S1PR5
SCHEMBL6000915 0.86 CTSL (0.38) ITGB3ITGA2BCTSLCTSBCTSS
SCHEMBL5999217 0.84 STAT3 (0.39) RAB9AMRE11TRPA1S1PR1S1PR3
SCHEMBL6001092 0.83 CTSL (0.38) CTSLCTSBCTSSRAB9AMRE11
SCHEMBL6000602 0.83 STAT3 (0.41) MRE11TRPA1
SCHEMBL6001059 0.83 RXRA (0.42) NPC1RAB9ASMN1; SMN2MRE11TRPA1
SCHEMBL6000143 0.82 MRE11 (0.40) MRE11TRPA1S1PR1S1PR3S1PR5
SCHEMBL6000650 0.82 MAPK1 (0.40) ITGB3ITGA2BCTSLCTSBCTSS
SCHEMBL6000047 0.81 STAT3 (0.41) MRE11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 ITGB3 3679/4885ITGA2B 3987/4885CTSL 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.